close
close

Gerresheimer: Starker Rückzug von Leerverkäufer Citadeladviseurs – Aktiennews (aktiencheck.de)

Düsseldorf (www.aktiencheck.de) – Leerverkäufer Citadel Advisors LLC fährt Netto-Leerverkaufsposition in Aktien der Gerresheimer AG kräftig zurück:

The short seller of the Hedge Fund Citadel Advisors LLC has learning sales activities in the Aktien of Verpackungsspezialisten Gerresheimer AG (ISIN: DE000A0LD6E6, WKN: A0LD6E, Ticker-Symbol: GXI, NASDAQ OTC-Symbol: GRRMF) deutlich abgebaut.

The financial profession of Kenneth C. Griffin established the Hedge Fund Citadel Advisors LLC in Sitz in Chicago, Illinois, USA on 23.08.2024 with a net sales position of 0.78% on 0.68% of the assets of Gerresheimer AG.

Aktuell puts the Hedge Fund’s Learnerskaufer following Net-Leerverkaufspositionen in the Gerresheimer AG-Aktien:

1.58% Qube Research & Technologies Limited (21.08.2024)
0.98% Marshall Wace LLP (23.08.2024)
0.68% Citadel Advisors LLC (23.08.2024)
0.59% WorldQuant, LLC (08/19/2024)
0.58% Lancaster Investment Management LLP (27.09.2019)
0.50% Voleon Capital Management LP (08.07.2024)

Total net sales position in the assets of Gerresheimer AG: less than 4.81%. Up to 0.50% is quoted in our report status as not subject to publication obligation not viewed.

Börsenplätze Gerresheimer-Action:

Xetra-Aktienkurs Gerresheimer-Action:
94.50 EUR -0.58% (26.08.2024, 11:49)

Tradegate Action Course Gerresheimer Action:
94.40 EUR -1.00% (26.08.2024, 11:37)

ISIN Gerresheimer Promotion:
DE000A0LD6E6

WKN Gerresheimer Action:
A0LD6E

Ticker symbol Gerresheimer-Aktie:
GXI

NASDAQ OTC Ticker-Symbol Gerresheimer-Action:
GRRMF

Brief profile Gerresheimer AG:

Gerresheimer (ISIN: DE000A0LD6E6, WKN: A0LD6E, Ticker Symbol: GXI, NASDAQ OTC Symbol: GRRMF) is a global partner for pharmaceutical, biotech, healthcare and cosmetic products with a comprehensive product range for medicine and cosmetic packaging for the Drug Delivery System. The company is an innovative product from the manufacturer with a love for the end product. Gerresheimer has a very good vision of a high quality of an innovation power, industrial competence that offers concentration on quality and customer focus. In the innovative and continuous development of the company, Gerresheimer has become an international network with innovative innovations and productions in Europe, America and Asia.

Gerresheimer produces weltweit with über 11,000 Mitarbeitern nah beim Kunden and erwirtschaftete 2022 a Umsatz von beef 1.82 Mrd. Euro. With its products and products, Gerresheimer plays a vital role in healthcare and human health. www.gerresheimer.com (26.08.2024/ac/a/d)